Resources
An immunologist tracks the serum concentration of protective neutralizing antibodies against rabies virus in two distinct adult patients over time. Patient A received a full prophylactic human diploid cell rabies vaccine (HDCV) series, leading to an active endogenous antibody response that achieves a half-life of functional immunity driven by memory cell turnover estimated at . Patient B suffered a severe animal bite and was immediately treated solely with equine rabies immunoglobulin (HRIG/RIG), resulting in an initial serum antibody concentration of that is degraded purely via passive physiological protein catabolism with a clearance half-life of . Assuming first-order clearance kinetics described by , calculate: (a) the first-order elimination rate constant for Patient B's passive antibodies (in ), and (b) the exact time (in days) required for Patient B's circulating passive antibody concentration to decline below the minimum protective threshold of .
Answer and steps
Final answer
(a) ; (b) .
Steps
Calculate the Elimination Rate Constant ()
Biological Context: Active vs. Passive Immunity
- Active Immunity (Patient A): Exposure to viral antigens stimulates the host's own B cells and T cells to undergo clonal selection, producing long-lived plasma cells and memory B cells. Consequently, protection persists over years ().
- Passive Immunity (Patient B): Administration of exogenous rabies immunoglobulin (RIG) confers immediate neutralizing protection without stimulating the recipient's immune system or generating memory cells. These foreign proteins undergo physiological catabolism with a characteristic IgG half-life of approximately .
Under first-order clearance kinetics, the concentration decreases according to:
At the half-life (), the concentration drops to half of the initial concentration ():
Substitute Patient B's clearance half-life of :
Calculate the Time () to Reach the Protective Threshold
Set the concentration equal to the protective threshold, :
Rearrange to solve for :
Take the natural logarithm of both sides:
Substitute , , and the unrounded value of :
Key Pitfall: Avoid using heavily rounded intermediate values of (e.g., using instead of ), as this introduces significant error into exponential decay calculations.
Typical errors
01 The student uses common logarithm (log10) instead of natural logarithm (ln) when relating rate constant to half-life.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
Because the model is formulated with the base as , setting yields , which simplifies to . Using underestimates the decay rate constant by a factor of .
- Step 2Correct
Your algebraic method for solving an exponential equation by taking the natural log of both sides was correct, but this step inherited your underestimated value of from Step 1.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly selected Patient B's half-life of for the passive clearance calculation.
You correctly recognized that can be solved for by taking the natural logarithm of the concentration ratio.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou substituted common logarithm instead of natural logarithm into the continuous decay rate formula .
REASONING PATH
Your ACEpath teacher’s suggested approach- Base Matching in Exponential Models
When an exponential equation is written with base (), inverse operations and rate constants must use the natural logarithm , where .
Always derive the relationship from first principles: .
CORRECTED PATH
ACEpath Teacher's DemonstrationRecalculate the first-order rate constant using the natural logarithm: .
Substitute the accurate into the threshold clearance equation: .
Evaluate the final quotient: .
(a) ; (b)
02 The student mistakenly uses Patient A's half-life of 5.0 years instead of Patient B's half-life of 21.0 days.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You used Patient A's active immunity half-life () rather than Patient B's passive antibody half-life (). Patient B received exogenous rabies immunoglobulin (passive immunity), which undergoes physiological protein catabolism with , whereas the 5.0-year half-life reflects memory cell turnover from Patient A's active vaccination.
- Step 2Correct
Your algebraic procedure for solving the first-order exponential decay equation was completely correct, but your final numerical answer was affected by substituting the incorrect rate constant from Step 1.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly recalled and applied the relationship between half-life and the first-order elimination rate constant, .
You correctly set up the exponential clearance equation and used logarithms to isolate time .
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou accidentally selected the half-life of memory-driven active immunity () rather than the half-life of passive immunoglobulin degradation () requested for Patient B.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisFailing to distinguish the physiological mechanisms of active versus passive immunity: active immunity generates memory cells that maintain long-term circulating antibodies for years, while passive immunity provides temporary, donor-derived antibodies that decay rapidly according to normal serum IgG catabolism.
REASONING PATH
Your ACEpath teacher’s suggested approach- Identify Immunity Type Before Extracting Parameters
Passive immunity (administered antibodies/immunoglobulins) decays rapidly via serum protein catabolism (), whereas active immunity (vaccines/antigens) persists over years due to memory B cells.
Always circle the specific patient or condition named in the prompt (Patient B = passive immunoglobulin) and verify that the half-life matches that clearance pathway before computing .
CORRECTED PATH
ACEpath Teacher's DemonstrationSubstitute Patient B's passive clearance half-life () into the rate constant formula: .
Substitute , , and into .
Evaluate the quotient: .
(a) ; (b)
03 The student assumes linear zero-order clearance by dividing the total concentration change by half-life instead of using first-order exponential decay.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2Correct
In first-order kinetics, clearance is exponential rather than linear. Dividing by produces an average rate over the first half-life, but the clearance rate continually slows down as antibody concentration falls.
- Step 3Correct
This result follows directly from your linear clearance assumption. Applying the exponential decay equation yields .
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly identified and applied the relationship between half-life and the first-order rate constant .
You correctly calculated the numerical value and units for in part (a).
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou treated passive antibody clearance as a constant-rate (zero-order) process by calculating an average loss per day and dividing total concentration drop by that rate, rather than solving the given first-order exponential equation for time.
REASONING PATH
Your ACEpath teacher’s suggested approach- First-Order Clearance Rule
For first-order elimination , the rate of change decreases as concentration declines; the time to reach any concentration is .
Whenever a problem specifies first-order kinetics or an exponential decay model, always isolate using natural logarithms rather than dividing concentration differences by a constant daily rate.
CORRECTED PATH
ACEpath Teacher's DemonstrationSet and : .
Divide by to isolate the exponential factor: , which gives .
Take the natural logarithm of both sides: .
Divide by the unrounded rate constant : .
(a) ; (b)
Lock it in
What is the relationship between the first-order rate constant and half-life for continuous exponential decay ?
. Base models strictly require the natural log of 2, not .
Similar question
A therapeutic monoclonal antibody follows first-order degradation kinetics with a serum elimination half-life of . If the initial peak serum level is , calculate the elimination rate constant (in ) and the time required for serum concentration to reach .
Answer
; . Key steps: , which represents exactly 3 half-lives (), or .
An infant receives maternal passive antibodies against measles that decay with a biological half-life of (). If the protective antibody concentration is initially and drops below protective efficacy at , find the duration of passive immunity in days.
Answer
. Key steps: ; .
Tetanus antitoxin (equine passive IgG) is cleared with . An active tetanus toxoid booster administered simultaneously causes host plasma cells to begin producing endogenous IgG after an initial lag of , which then doubles every until day . If passive antitoxin starts at , write the expression for the passive antibody concentration at and evaluate it.
Answer
. Key steps: ; elapsed time equals exactly half-lives, giving .